Cargando…
Non-coding RNA in cancer drug resistance: Underlying mechanisms and clinical applications
Cancer is one of the most frequently diagnosed malignant diseases worldwide, posing a serious, long-term threat to patients’ health and life. Systemic chemotherapy remains the first-line therapeutic approach for recurrent or metastatic cancer patients after surgery, with the potential to effectively...
Autores principales: | Zhou, Xuehao, Ao, Xiang, Jia, Zhaojun, Li, Yiwen, Kuang, Shouxiang, Du, Chengcheng, Zhang, Jinyu, Wang, Jianxun, Liu, Ying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428469/ https://www.ncbi.nlm.nih.gov/pubmed/36059609 http://dx.doi.org/10.3389/fonc.2022.951864 |
Ejemplares similares
-
The regulation of PBXs and their emerging role in cancer
por: Liu, Ying, et al.
Publicado: (2022) -
Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance
por: Liu, Ying, et al.
Publicado: (2022) -
Non-coding RNAs in lung cancer: molecular mechanisms and clinical applications
por: Liu, Ying, et al.
Publicado: (2023) -
Mechanisms of Action And Clinical Implications of MicroRNAs in the Drug Resistance of Gastric Cancer
por: Liu, Ying, et al.
Publicado: (2021) -
Exosomal Long Non-Coding RNA ANCR Mediates Drug Resistance in Osteosarcoma
por: Hu, Xin, et al.
Publicado: (2022)